MedWatch

A part of Watch Media

Amnesty warns Danish firms at Dubai health event: ”Do your due diligence”

More than 20 Danish medtech companies have traveled to a huge health event currently taking place in Dubai, where torture, exploitation and human rights violations are still part of everyday life. In principle, this is OK, says Amnesty, while cautioning companies to perform thorough background checks of potential customers.

A record number of Danish firms are participating in this year's health expo, Arab Health, which takes place in Dubai. The photograph depicts last year's event | Photo: Health Tech / PR
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen

At least 23 Danish life science companies are eagerly canvassing the huge health expo, Arab Health, which is currently being held in Dubai. Buyers, distributors and representatives from healthcare systems in the region are mingling there in the hopes of getting million-dollar order contracts signed, money that’s likely from the Saudi oil adventure, which has made the Middle East astoundingly rich.

Participants are here despite the constant criticisms leveled at countries on the Arabian Peninsula from human rights organizations like Amnesty International and Human Rights Watch. On the face of it, their presence is OK, says Amnesty.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

Britt Meelby Jensen, new CEO of Ambu | Foto: Novo Holdings / PR

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

Today, Juan Jose Gonzalez steps down from his role as chief executing of Ambu | Foto: Ambu/PR

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

  1. Top news from MedWatch this week
  2. Outgoing Ambu CEO commends colleagues
  3. Nine new drugs recommended for approval by CHMP at May meeting
  4. Danish Medicines Council rejects Novartis breast cancer drug
  5. Analysts have great faith in incoming Ambu CEO
  6. Britt Meelby Jensen wants to rebuild trust in Ambu
  7. Ambu board had started headhunting process long before firing of CEO
  8. ALK CEO sells shares for USD 1.5m
  9. Novo Nordisk regains Novorapid supply capacity
  10. Ambu appoints Britt Meelby Jensen new CEO
  11. Zealand Pharma reports positive phase III results against congenital hyperinsulinism
  12. Audientes generates first-ever revenue in Q1
  13. Almirall and Evotec to collaborate on multiple severe skin disease targets
  14. Bavarian lands monkeypox vaccine contract with unnamed European country
  15. Thousands of collaborative research papers with China pose threat to Europe, authorities worry

See all

Job

See all jobs

See all jobs